24478-106-01 |
24478-106 |
HUMAN PRESCRIPTION DRUG |
DYANAVEL XR |
amphetamine |
TABLET, EXTENDED RELEASE |
ORAL |
20220801 |
N/A |
NDA |
NDA210526 |
NextWave Pharmaceuticals, Inc |
AMPHETAMINE |
5 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-106-01) |
24478-108-01 |
24478-108 |
HUMAN PRESCRIPTION DRUG |
DYANAVEL XR |
amphetamine |
TABLET, EXTENDED RELEASE |
ORAL |
20220801 |
N/A |
NDA |
NDA210526 |
NextWave Pharmaceuticals, Inc |
AMPHETAMINE |
10 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-108-01) |
24478-109-01 |
24478-109 |
HUMAN PRESCRIPTION DRUG |
DYANAVEL XR |
amphetamine |
TABLET, EXTENDED RELEASE |
ORAL |
20220801 |
N/A |
NDA |
NDA210526 |
NextWave Pharmaceuticals, Inc |
AMPHETAMINE |
15 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-109-01) |
24478-110-01 |
24478-110 |
HUMAN PRESCRIPTION DRUG |
DYANAVEL XR |
amphetamine |
TABLET, EXTENDED RELEASE |
ORAL |
20220801 |
N/A |
NDA |
NDA210526 |
NextWave Pharmaceuticals, Inc |
AMPHETAMINE |
20 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-110-01) |